Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Clark

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Biological Chemistry|November 28, 2024
Molecular determinants of the selectivity and potency of α-conotoxin Vc1.1 for human nicotinic acetylcholine receptorsHan-Shen Tae, Andrew Hung, Richard J Clark, et al.
Chembiochem : a European Journal of Chemical Biology|September 17, 2010
Structural and functional analysis of human liver-expressed antimicrobial peptide 2Sónia Troeira Henriques, Chia Chia Tan, David J Craik, et al.
Scientific Reports|July 4, 2018
Discovery of peptide probes to modulate oxytocin-type receptors of insectsPeter Keov, Zita Liutkevičiūtė, Roland Hellinger, et al.
Journal of Natural Products|August 20, 2010
Isolation, sequencing, and structure-activity relationships of cyclotidesDavid C Ireland, Richard J Clark, Norelle L Daly, et al.
The Biochemical Journal|October 7, 2005
Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motifNorelle L Daly, Richard J Clark, Manuel R Plan, et al.
Frontiers in Endocrinology|September 13, 2021
LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of ObesityXuehan Lu, Lili Huang, Zhengxiang Huang, et al.
The Journal of Biological Chemistry|November 21, 2014
Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonistShiva N Kompella, Andrew Hung, Richard J Clark, et al.
The Journal of General Physiology|April 2, 2014
Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activationGéza Berecki, Jeffrey R McArthur, Hartmut Cuny, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 15, 2010
Cyclization of conotoxins to improve their biopharmaceutical propertiesRichard J Clark, Muharrem Akcan, Quentin Kaas, et al.
Biochemistry|June 5, 2003
Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activityDaniel G Barry, Norelle L Daly, Richard J Clark, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|November 28, 2024
Molecular determinants of the selectivity and potency of α-conotoxin Vc1.1 for human nicotinic acetylcholine receptorsHan-Shen Tae, Andrew Hung, Richard J Clark, et al.
Chembiochem : a European Journal of Chemical Biology|September 17, 2010
Structural and functional analysis of human liver-expressed antimicrobial peptide 2Sónia Troeira Henriques, Chia Chia Tan, David J Craik, et al.
Scientific Reports|July 4, 2018
Discovery of peptide probes to modulate oxytocin-type receptors of insectsPeter Keov, Zita Liutkevičiūtė, Roland Hellinger, et al.
Journal of Natural Products|August 20, 2010
Isolation, sequencing, and structure-activity relationships of cyclotidesDavid C Ireland, Richard J Clark, Norelle L Daly, et al.
The Biochemical Journal|October 7, 2005
Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motifNorelle L Daly, Richard J Clark, Manuel R Plan, et al.
Frontiers in Endocrinology|September 13, 2021
LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of ObesityXuehan Lu, Lili Huang, Zhengxiang Huang, et al.
The Journal of Biological Chemistry|November 21, 2014
Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonistShiva N Kompella, Andrew Hung, Richard J Clark, et al.
The Journal of General Physiology|April 2, 2014
Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activationGéza Berecki, Jeffrey R McArthur, Hartmut Cuny, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 15, 2010
Cyclization of conotoxins to improve their biopharmaceutical propertiesRichard J Clark, Muharrem Akcan, Quentin Kaas, et al.
Biochemistry|June 5, 2003
Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activityDaniel G Barry, Norelle L Daly, Richard J Clark, et al.
Pageof 12